Gosset KriSan Biotech General Information
KriSan Biotech is an international CDMO specializing in complex small molecules, peptides, oligonucleotides (including LNP formulations), antibody-drug conjugates (ADC), and peptide-drug conjugates. The company has completed over 90 projects for more than 45 global clients across the US, Europe, Japan, Middle East, Singapore, and Taiwan. It holds PIC/S GMP certification and supports customers from preclinical through commercial production.
Contact Information
Taiwan
Drug Pipeline
No pipeline data available
Key Partnerships
Sartorius – technical partnership for ADC drug substance production line buildout., Mycenax Biotech – collaboration on ADC design/development/manufacturing value chain., OncoArendi Therapeutics – supply agreement for active pharmaceutical ingredients from Pre‑IND to Phase II clinical trials., 晟德集團（Synmosa Group）– strategic investor/partner since late 2023, 永昕生醫（Mycenax Biotech）– strategic investor/partner since late 2023
KriSan Biotech Funding
No funding data available